DRW Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-33,916
Closed -$2.13M 1019
2026
Q1
$2.13M Buy
33,916
+29,267
+630% +$2.34M 0.03% 203
2025
Q4
$442K Buy
4,649
+268
+6% +$26.3K 0.01% 503
2025
Q3
$424K Sell
4,381
-3,032
-41% -$314K 0.01% 688
2025
Q2
$796K Buy
+7,413
New +$750K 0.02% 337
2025
Q1
Sell
-2,605
Closed -$233K 604
2024
Q4
$233K Buy
+2,605
New +$229K 0.01% 495
2024
Q3
Sell
-4,890
Closed -$376K 575
2024
Q2
$376K Sell
4,890
-3,151
-39% -$231K 0.01% 369
2024
Q1
$550K Buy
+8,041
New +$517K 0.01% 219
2023
Q2
Sell
-7,043
Closed -$352K 352
2023
Q1
$352K Buy
+7,043
New +$332K 0.01% 241
2022
Q4
Sell
-5,653
Closed -$219K 270
2022
Q3
$219K Buy
+5,653
New +$227K ﹤0.01% 222
2022
Q2
Sell
-6,664
Closed -$295K 258
2022
Q1
$295K Buy
+6,664
New +$289K 0.01% 209
2021
Q3
Sell
-5,155
Closed -$220K 266
2021
Q2
$220K Buy
+5,155
New +$217K 0.01% 262
2018
Q1
Sell
-19,248
Closed -$477K 217
2017
Q4
$477K Buy
+19,248
New +$531K 0.05% 229

Other funds holding BSX

DRW Securities's BSX Position: Q2 2026 in Review

DRW Securities sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 33,916 shares — an estimated $2.13M sold.

DRW Securities first reported a position in BSX in Q4 2017 and held it in 12 quarters. The position peaked at $2.13M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DRW Securities reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 33,916 Boston Scientific shares in Q2 2026, an estimated $2.13M.
  • DRW Securities first reported a position in Boston Scientific in Q4 2017 and held it in 12 quarters.
  • DRW Securities's Boston Scientific position peaked at $2.13M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.